EEG Spectral Features Discriminate between Alzheimer’s and Vascular Dementia
نویسندگان
چکیده
منابع مشابه
EEG Spectral Features Discriminate between Alzheimer’s and Vascular Dementia
Alzheimer's disease (AD) and vascular dementia (VaD) present with similar clinical symptoms of cognitive decline, but the underlying pathophysiological mechanisms differ. To determine whether clinical electroencephalography (EEG) can provide information relevant to discriminate between these diagnoses, we used quantitative EEG analysis to compare the spectra between non-medicated patients with ...
متن کاملCognitive Features of Vascular Dementia
A lot of studies have focused on cerebrovascular disease as an independent cause of dementia. In a study with consecutive stroke patients aged sixty and older, 26.3% of patients were demented three months after the stroke (Desmond et al., 2000). Within the demented patients, 57.1% had dementia directly related with stroke and 38.7% had dementia due to the combined effects of stroke and Alzheime...
متن کاملautomatic diagnosis of mild cognitive impairment using eeg spectral features
alzheimer’s disease (ad) is one of the most expensive and fatal disease in elderly population. up to now no cure have been found for ad, so early stage diagnosis is the only way to control it. mild cognitive impairment (mci) usually is the early stage of ad which is defined as decreasing in mental abilities such a cognition, memory and speech not too severe to interfere daily activities. mci di...
متن کاملCerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
Alpha-synuclein is the major constituent of Lewy bodies found in neurons in dementia with Lewy bodies (DLB) and might be of diagnostic value as a biomarker for DLB. We hypothesized that, as a consequence of increased accumulation of alpha-synuclein intraneuronally in DLB, the levels of alpha-synuclein in cerebrospinal fluid (CSF) of DLB patients would be lower than in other dementias. Our objec...
متن کاملCerebrospinal fluid a-synuclein does not discriminate between dementia disorders
a-Synuclein is the major constituent of Lewy bodies found in neurons in dementia with Lewy bodies (DLB) and might be of diagnostic value as a biomarker for DLB. We hypothesized that, as a consequence of increased accumulation of a-synuclein intraneuronally in DLB, the levels of asynuclein in cerebrospinal fluid (CSF) of DLB patients would be lower than in other dementias. Our objective was to i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Neurology
سال: 2015
ISSN: 1664-2295
DOI: 10.3389/fneur.2015.00025